Thymalin

Thymalin is presented as a thymus-derived peptide mixture with short identified fractions such as EW and KE. The proposed mechanism is immunomodulatory and gene-regulatory: source material links these peptides to interactions with DNA or histone-associated regions that may influence cytokine signaling, heat-shock protein expression, cellular differentiation, T- and B-lymphocyte function, and phagocytosis. Because the material is a complex extract, the evidence does not support reducing its action to one receptor or one molecular target.

The supplied research summary places most Thymalin literature in Russian and Khavinson-associated research programs, spanning cell experiments, animal studies, observational work, and clinical reports. It cites reviews describing lymphocyte and immune-function findings, fewer acute respiratory disease observations in older groups, geroprotective claims, mortality observations in older subjects receiving thymus and pineal peptides, and a study of immune-status regulation in severe COVID-19 among older patients. The source also cautions that although some randomized or placebo-controlled data exist, studies are commonly small, regionally concentrated, and not replicated at a scale expected for major Western regulatory review.